Companies: 10,793     total market cap: โ‚น12465.385 T
๐Ÿ‡ฉ๐Ÿ‡ช Deutsch๐Ÿ‡ซ๐Ÿ‡ท Franรงais
$USD๐Ÿ‡บ๐Ÿ‡ธโ‚ฌEUR๐Ÿ‡ช๐Ÿ‡บยฃGBP๐Ÿ‡ฌ๐Ÿ‡ง$CAD๐Ÿ‡จ๐Ÿ‡ฆ$AUD๐Ÿ‡ฆ๐Ÿ‡บ$NZD๐Ÿ‡ณ๐Ÿ‡ฟ$HKD๐Ÿ‡ญ๐Ÿ‡ฐ$SGD๐Ÿ‡ธ๐Ÿ‡ฌ
Repligen
RGEN
#2592
Rank
โ‚น609.31 B
Marketcap
๐Ÿ‡บ๐Ÿ‡ธ United States
Country
โ‚น10,817
Share price
-1.64%
Change (1 day)
-1.72%
Change (1 year)
๐Ÿงฌ Biotech
Categories

Repligen (RGEN) - Total assets

Total assets on the balance sheet as of December 2025 : โ‚น274.13 Billion

According to Repligen 's latest financial reports the company's total assets are โ‚น274.13 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Repligen - Total assets on balance sheet (from 2001 to 2025)

Total assets by year

Year Total assets Change
2025-12-31โ‚น264.79 B9.08%
2024-12-31โ‚น242.74 B2.99%
2023-12-31โ‚น235.69 B12.51%
2022-12-31โ‚น209.49 B19.34%
2021-12-31โ‚น175.53 B26.13%
2020-12-31โ‚น139.16 B39.38%
2019-12-31โ‚น99.84 B84.34%
2018-12-31โ‚น54.16 B14.09%
2017-12-31โ‚น47.47 B141.81%
2016-12-31โ‚น19.63 B102.02%
2015-12-31โ‚น9.71 B19.52%
2014-12-31โ‚น8.13 B10.93%
2013-12-31โ‚น7.32 B38%
2012-12-31โ‚น5.31 B
2011-03-31โ‚น3.21 B0.88%
2010-03-31โ‚น3.18 B-14.55%
2009-03-31โ‚น3.72 B35.13%
2008-03-31โ‚น2.75 B119.76%
2007-03-31โ‚น1.25 B-2.1%
2006-03-31โ‚น1.28 B6.79%
2005-03-31โ‚น1.20 B-6.53%
2004-03-31โ‚น1.28 B0.8%
2003-03-31โ‚น1.27 B-10.33%
2002-03-31โ‚น1.42 B-5.23%
2001-03-31โ‚น1.49 B

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
Pfizer
PFE
โ‚น19.345 T 6,956.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Thermo Fisher Scientific
TMO
โ‚น10.255 T 3,640.82%๐Ÿ‡บ๐Ÿ‡ธ USA
General Electric
GE
โ‚น12.097 T 4,312.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚น8.367 T 2,952.45%๐Ÿ‡บ๐Ÿ‡ธ USA
Sangamo Therapeutics
SGMO
โ‚น8.23 B-96.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Novavax
NVAX
โ‚น109.34 B-60.11%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
โ‚น430.44 B 57.02%๐Ÿ‡บ๐Ÿ‡ธ USA
Bio-Techne
TECH
โ‚น234.45 B-14.48%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
โ‚น705.77 B 157.45%๐Ÿ‡บ๐Ÿ‡ธ USA
Charles River Laboratories
CRL
โ‚น663.15 B 141.90%๐Ÿ‡บ๐Ÿ‡ธ USA

What is the market capitalization of a company?

The market capitalization sometimes referred as Marketcap, is the value of a publicly listed company.
In most cases it can be easily calculated by multiplying the share price with the amount of outstanding shares.

DISCLAIMER

CompaniesMarketCap is not associated in any way with CoinMarketCap.com
Stock prices are delayed, the delay can range from a few minutes to several hours.
Company logos are from the CompaniesLogo.com logo database and belong to their respective copyright holders. Companies Marketcap displays them for editorial purposes only.

Contact

For inquiries or if you want to report a problem write to hello@8marketcap.com

Links

- Privacy policy

- Terms and conditions

© 2025 CompaniesMarketcap.com